Doç. Dr. UĞUR SELEK

1. Determining Residents' Concerns About Staying Up to Date: Turkish Society for Radiation Oncology-Young Radiation Oncologists' Cross-Sectional National Survey (TROD/GROG 007)

Yilmaz M. T., KAHVECİOĞLU A., GÜLTEKİN M., ATALAR B., ÖZYİĞİT G., Selek U.

JCO GLOBAL ONCOLOGY , 2025 (ESCI, Scopus)

2. Oligometastatic Bone Disease in Castration-Sensitive Prostate Cancer Patients Treated With Stereotactic Body Radiotherapy Using Ga-68-PSMA PET/CT TROD 09-004 Study

Onal C., ÖZYİĞİT G., Akgun Z., Atalar B., Igdem S., Oymak E., et al.

CLINICAL NUCLEAR MEDICINE , cilt.46, sa.6, ss.465-470, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

3. Treatment outcomes of metastasis-directed treatment using(68)Ga-PSMA-PET/CT for oligometastatic or oligorecurrent prostate cancer: Turkish Society for Radiation Oncology group study (TROD 09-002)

HÜRMÜZ P., Onal C., ÖZYİĞİT G., Igdem S., Atalar B., Sayan H., et al.

STRAHLENTHERAPIE UND ONKOLOGIE , cilt.196, sa.11, ss.1034-1043, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

4. Three Dimensional Conformal Radiotherapy and Androgen Deprivation Therapy in Patients with Clinically Localized Prostate Cancer; Hacettepe University Experience

ÖZDEMİR Y., Akyol F., ÖZYİĞİT G., HÜRMÜZ P., Onal C., Selek U., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.25, sa.2, ss.107-117, 2015 (SCI-Expanded, Scopus, TRDizin)

5. Clinical Features and Prognostic Factors of Hodgkin's Lymphoma: A Single Center Experience

KILIÇKAP S., BARIŞTA İ., ÜLGER Ş., ÇELİK İ., SELEK U., YILDIZ F., et al.

BALKAN MEDICAL JOURNAL , cilt.30, sa.2, ss.178-185, 2013 (SCI-Expanded, Scopus, TRDizin)

6. Long-term complications in Hodgkin's lymphoma survivors

KILIÇKAP S., BARIŞTA İ., Ulger S., ÇELİK İ., SELEK U., Gullu I., et al.

TUMORI , cilt.98, sa.5, ss.601-606, 2012 (SCI-Expanded, Scopus)

7. Comparison of intracavitary brachytherapy and stereotactic body radiotherapy dose distribution for cervical cancer

CENGİZ M., DOĞAN A., ÖZYİĞİT G., Erturk E., YILDIZ F., SELEK U., et al.

BRACHYTHERAPY , cilt.11, sa.2, ss.125-129, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

8. Utility of "Over D1" or D1 Nodal Dissections in Predicting Outcome of Patients with Gastric Adenocarcinoma Treated with Postoperative Concurrent Chemoradiotherapy

SELEK U., Zorlu F., ÖZYİĞİT G., HÜRMÜZ P., YALÇIN Ş., CENGİZ M.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.22, sa.4, ss.233-238, 2012 (SCI-Expanded, Scopus, TRDizin)

9. The Efficiency and Toxicity of Hemithoracic Radiotherapy After Extra Pleural Pneumonectomy in Malign Pleural Mesothelioma

HÜRMÜZ P., Akyol F., SELEK U., ÖZYİĞİT G., DOĞAN R., Ozdemir N., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.20, sa.1, ss.20-26, 2010 (SCI-Expanded, Scopus, TRDizin)

10. Cranial Prophylactic Irradiation in Locally Advanced Non-Small Cell Lung Carcinoma: Current Status and Future Perspectives

Topkan E., Yildirim B. A., SELEK U., Yavuz M. N.

ONCOLOGY , cilt.76, sa.3, ss.220-228, 2009 (SCI-Expanded, Scopus)

11. Second line palliative endobronchial radiotherapy with HDR Ir 192 in recurrent lung carcinoma

Zorlu A. F., SELEK U., Emri S., Gurkaynak M., Akyol F. H.

YONSEI MEDICAL JOURNAL , cilt.49, sa.4, ss.620-624, 2008 (SCI-Expanded, Scopus)

12. Percent positive axillary involvement predicts for the development of brain metastasis in high-risk patients with nonmetastatic breast cancer receiving post-mastectomy radiotherapy

Atahan I. L., ÖZYİĞİT G., YILDIZ F., Gurkaynak M., Selek U., Sari S., et al.

BREAST JOURNAL , cilt.14, sa.3, ss.245-249, 2008 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

13. Effect of bladder distension on dose distribution of intracavitary brachytherapy for cervical cancer: Three-dimensional computed tomography plan evaluation

CENGİZ M., Gurdalli S., SELEK U., YILDIZ F., Saglam Y., Ozyar E., et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , cilt.70, sa.2, ss.464-468, 2008 (SCI-Expanded, Scopus)

14. Lung adenocarcinoma with skin metastasis

HÜRMÜZ P., SELEK U., Zorlu F., Tekuzman G.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.18, sa.1, ss.39-41, 2008 (SCI-Expanded, Scopus, TRDizin)

15. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer

Atahan I. L., YILDIZ F., ÖZYİĞİT G., Sari S., Gurkaynak M., Selek U., et al.

ACTA ONCOLOGICA , cilt.47, sa.2, ss.232-238, 2008 (SCI-Expanded, Scopus)

16. Boost dose back again in elderly

GÜLTEKİN M., SELEK U., ÖZYİĞİT G., CENGİZ M., Yavas O., YILDIZ F.

JOURNAL OF CLINICAL ONCOLOGY , cilt.25, sa.36, ss.5843-5844, 2007 (SCI-Expanded, Scopus)

17. Is mastectomy superior to breast-conserving treatment for young women?: In regard to Coulombe et al. (Int J Radiat Oncol Biol Phys 2007;67 : 1282-1290)

Yazici G., Selek U., Yildiz F., Ozyigit G., Cengiz M.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , cilt.69, sa.2, ss.640, 2007 (SCI-Expanded, Scopus)

18. Comment on "cranial location of level II lymph nodes in laryngeal cancer: Implications for elective nodal target volume delineation": In regard to Braam et al. (Int J Radiat Oncol Biol Phys 2007;67.462-468)

Ozyigit G., Selek U., Cengiz M., Yildiz F.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , cilt.68, sa.5, ss.1582-1583, 2007 (SCI-Expanded, Scopus)

19. Craniospinal radiotherapy in adult medulloblastoma

Selek U., Zorlu F., Hurmuz P., Cengiz M., Turker A., Soylemezoglu F., et al.

STRAHLENTHERAPIE UND ONKOLOGIE , cilt.183, sa.5, ss.236-240, 2007 (SCI-Expanded, Scopus)

20. Astrocytic tumors in children: treatment results from a single institution

Varan A., Akyuz C., Akalan N., Atahan L., Soylemezoglu F., Selek U., et al.

CHILDS NERVOUS SYSTEM , cilt.23, sa.3, ss.315-319, 2007 (SCI-Expanded, Scopus)

21. Change in blood chemistry may explain higher toxicity of total body irradiation for bone marrow transplantation

Cengiz M., Cetin E., Yildiz F., Selek U., Aydinkarahaliloglu E.

MEDICAL HYPOTHESES , cilt.68, sa.3, ss.554-557, 2007 (SCI-Expanded, Scopus)

22. Treatment results of 165 pediatric patients with non-metastatic nasopharyngeal carcinoma: A Rare Cancer Network study

Ozyar E., Selek U., Laskar S., Uzel O., Anacak Y., Ben-Arush M., et al.

RADIOTHERAPY AND ONCOLOGY , cilt.81, sa.1, ss.39-46, 2006 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

23. Use of CT simulation for treatment of cervical cancer to assess the adequacy of lymph node coverage of conventional pelvic fields based on bony landmarks: In regard to Finlay et al. (Int J Radiat Oncol Biol Phys 2006;64 : 205-209)

Yazici G., Yildiz F., Cengiz M., Ozyigit G., Selek U., GENC M., et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , cilt.65, sa.5, ss.1594, 2006 (SCI-Expanded, Scopus)

24. Radiotherapy in the management of Kaposi's sarcoma: Comparison of 8 Gy versus 6 Gy

Yildiz F., Genc M., Akyurek S., Cengiz M., Ozyar E., Selek U., et al.

JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION , cilt.98, sa.7, ss.1136-1139, 2006 (SCI-Expanded, Scopus)

25. Postoperative radiotherapy in cranial ganglioglioma

Zorlu F., Selek U., Onal C., Soylemezoglu F., Gurkaynak M.

JOURNAL OF NEURO-ONCOLOGY , cilt.77, sa.3, ss.321-324, 2006 (SCI-Expanded, Scopus)